Virtual screening for submicromolar leads of tRNA-guanine transglycosylase based on a new unexpected binding mode detected by crystal structure analysis

Journal of Medicinal Chemistry

Volumn 46, Issue 7, 2003, Pages 1133-1143

  Brenk, Ruth ^a   Naerum, Lars ^b,d   Grädler, Ulrich ^a,e   Gerber, Hans Dieter ^a   Garcia, George A ^c   Reuter, Klaus ^a   Stubbs, Milton T ^a   Klebe, Gerhard ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b NOVO NORDISK A S   (Denmark)

^c UNIVERSITY OF MICHIGAN   (United States)

^d Arpida Ltd   (Switzerland)

^e ALTANA Pharma   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOPHTHALHYDRAZIDE; ENZYME INHIBITOR; GLYCOSYLTRANSFERASE; PYRIDAZINONE DERIVATIVE; QUEUINE; QUEUINE TRANSFER RIBONUCLEIC ACID RIBOSYLTRANSFERASE; TRANSFER RNA; TRANSFER RNA GUANINE TRANSGLYCOSYLASE INHIBITOR; UNCLASSIFIED DRUG;

ANTICODON; ARTICLE; CRYSTAL STRUCTURE; DRUG DESIGN; DRUG SCREENING; ENZYME BINDING; EUBACTERIUM; GENE MUTATION; HYDROGEN BOND; LIGAND BINDING; PHARMACOPHORE; SHIGELLA FLEXNERI; VIRTUAL REALITY; X RAY CRYSTALLOGRAPHY; ZYMOMONAS MOBILIS;

BINDING SITES; COMBINATORIAL CHEMISTRY TECHNIQUES; CRYSTALLOGRAPHY, X-RAY; DATABASES, FACTUAL; ENZYME INHIBITORS; GUANINE; HYDRAZINES; LIGANDS; MODELS, MOLECULAR; MOLECULAR CONFORMATION; PENTOSYLTRANSFERASES; PIPERIDINES; PTERINS; PYRAZOLES; PYRIDAZINES; QUANTUM THEORY; STRUCTURE-ACTIVITY RELATIONSHIP; ZYMOMONAS;

EID: 0345269288     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm0209937     Document Type: Article

References (54)

1. Kotloff, K.; Winickoff, J.; Ivanoff, B.; Clemens, J.; Swerdlow, D.; et al. Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull. WHO 1999, 77, 651-666.
2. Replogle, M. L.; Fleming, D. W.; Cieslak, P. R. Emergence of antimicrobial-resistant shigellosis in Oregon. Clin. Infect. Dis. 2000, 30, 515-519.
3. Khan, W. A.; Seas, C.; Dhar, U.; Salam, M. A.; Bennish, M. L. Treatment of shigellosis: V. Comparison of azithromycin and ciprofloxacin. A double-blind, randomized, controlled trial. Ann. Intern. Med. 1997, 1, 697-703.
4. Overcoming Antimicrobial Resistance, Word Health Report on Infectious Diseases. http://www.who.int/infectious-disease-report/2000/index.html (accessed 2000).
5. Okada, N.; Sasakawa, C.; Tobe, T.; Yamada, M.; Nagai, S.; et al. Virulence-associated chromosomal loci of Shigella flexneri identified by random Tn5 insertion mutagenesis. Mol. Microbiol. 1991, 5, 187-195.
6. Durand, J. M.; Dagberg, B.; Uhlin, B. E.; Bjork, G. R. Transfer RNA modification, temperature and DNA superhelicity have a common target in the regulatory network of the virulence of Shigella flexneri: the expression of the virF gene. Mol. Microbiol. 2000, 35, 924-935.
7. Okada, N.; Nishimura, S. Isolation and characterization of a guanine insertion enzyme, a specific tRNA transglycosylase, from Escherichia coli. J. Biol. Chem. 1979, 254, 3061-3066.
8. Kittendorf, J. D.; Barcomb, L. M.; Nonekowski, S. T.; Garcia, G. A. tRNA-Guanine Transglycosylase from Escherichia coli: Molecular Mechanism and Role of Aspartate 89. Biochemistry 2001, 40, 14123-14133.
9. Slany, R. K.; Kersten, H. Genes, enzymes and coenzymes of queuosine biosynthesis in procaryotes. Biochimie 1994, 76, 1178-1182.
10. Frey, B.; McCloskey, J.; Kersten, W.; Kersten, H. New function of vitamin B12: cobamide-dependent reduction of epoxyqueuosine to queuosine in tRNAs of Escherichia coli and Salmonella typhimurium. J. Bacteriol. 1988, 170, 2078-2082.
11. Curran, L. Modified nucleosides in translation. In Modifiaction and Editing of RNA; American Society for Microbiology Press: Washington, DC, 1998; pp 493-516.
12. Björk, G. R. Biosynthesis and function of modified nucleosides in tRNA. In tRNA: Structure, Biosynthesis, and Function; American Society for Microbiology Press: Washington, DC, 1995; pp 165-205.
13. Björk, G. Stable RNA modification. In Escherichia coli and Salmonella: Cellular and Molecular Biology, 2nd ed.; American Society for Microbiology Press: Washington, DC, 1996; pp 861-886.
14. Durand, J. M.; Okada, N.; Tobe, T.; Watarai, M.; Fukuda, I.; et al. vacC, a virulence-associated chromosomal locus of Shigella flexneri, is homologous to tgt, a gene encoding tRNA-guanine transglycosylase (Tgt) of Escherichia coli K-12. J. Bacteriol. 1994, 176, 4627-4634.
15. Romier, C.; Reuter, K.; Suck, D.; Ficner, R. Crystal structure of tRNA-guanine transglycosylase: RNA modification by base exchange. EMBO J. 1996, 15, 2850-2857.
16. Romier, C.; Meyer, J. E.; Suck, D. Slight sequence variations of a common fold explain the substrate specificities of tRNA-guanine transglycosylases from the three kingdoms. FEBS Lett. 1997, 416, 93-98.
17. Klebe, G. Recent developments in structure-based drug design. J. Mol. Med. 2000, 78, 269-281.
18. Grädler, U.; Gerber, H. D.; Goodenough-Lashua, D. M.; Garcia, G. A.; Ficner, R.; et al. A New Target for Shigellosis: Rational Design and Crystallographic Studies of Inhibitors of tRNA-guanine Transglycosylase. J. Mol. Biol. 2001, 306, 455-467.
19. Meyer, E. A. Unpublished results.
20. Nærum, L.; Graedler, U.; Klebe, G. Virtual screening based on tRNA-guanine transglycosylase. In Rational Approaches to Drug Design; Prous Science: Barcelona, Spain, 2001; pp 400-402.
21. Grädler, U.; Ficner, R.; Garcia, G. A.; Stubbs, M. T.; Klebe, G.; et al. Mutagenesis and crystallographic studies of Zymomonas mobilis tRNA-guanine transglycosylase to elucidate the role of serine 103 for enzymatic activity. FEBS Lett 1999, 454, 142-146.
22. Meyer, E. A.; Brenk, R.; Castellano, R. K.; Furler, M.; Klebe, G.; et al. De Novo Design, Synthesis, and in Vitro Evaluation of Inhibitors for Prokaryotic tRNA-guanine Transglycosylase: A Dramatic Sulfur Effect on Binding Affinity. ChemBioChem 2002, 3, 250-253.
23. Verdonk, M. L.; Cole, J. C.; Taylor, R. SuperStar: a knowledge-based approach for identifying interaction sites in proteins. J. Mol. Biol. 1999, 289, 1093-108.
24. Gohlke, H.; Hendlich, M.; Klebe, G. Predicting binding modes, binding affinities and "hot spots" for protein-ligand complexes using a knowledge-based scoring function. Perspect. Drug Discov. Des. 2000, 20, 115-144.
25. Grüneberg, S.; Wendt, B.; Klebe, G. Subnanomolar Inhibitors from Computer Screening: A Model Study Using Human Carbonic Anhydrase II. Angew. Chem., Int. Ed. 2001, 40, 389-393.
26. Grüneberg, S.; Stubbs, M.; Klebe, G. Successful Virtual Screening for Novel Inhibitors of Human Carbonic Anhydrase: Stragegy and Experimental Confirmation. In press.
27. Unity, Chemical Information Software, version 4.2.1; Tripos, Inc.: St. Louis, MO.
28. Selector; Tripos, Inc.: St. Louis MO.
29. Rarey, M.; Kramer, B.; Lengauer, T.; Klebe, G. A fast flexible docking method using an incremental construction algorithm. J. Mol. Biol. 1996, 261, 470-489.
30. Hann, M. M.; Leach, A. R.; Harper, G. Molecular complexity and its impact on the probability of finding leads for drug discovery. J. Chem. Inf. Comput. Sci. 2001, 41, 856-864.
31. Oprea, T. I.; Davis, A. M.; Teague, S. J.; Leeson, P. D. Is There a Difference between Leads and Drugs? A Historical Perspective. J. Chem. Inf. Comput. Sci. 2001, 41, 1308-1315.
32. Gerber, P. R. Charge distribution from a simple molecular orbital type calculation and non-bonding interaction terms in the force field MAB. J. Comput.-Aided. Mol. Des. 1998, 12, 37-51.
33. Jacobson, K. B.; Farkas, W. R.; Katze, J. R. Presence of queuine in Drosophila melanogaster: correlation of free pool with queuosine content of tRNA and effect of mutations in pteridine metabolism. Nucleic Acids Res. 1981, 9, 2351-2366.
34. Hoops, G. C.; Townsend, L. B.; Garcia, G. A. Mechanism-based inactivation of tRNA-guanine transglycosylase from Escherichia coli by 2-amino-5-(fluoromethyl)pyrrolo[2,3-d]pyrimidin-4(3H)-one. Biochemistry 1995, 34, 15539-15544.
35. Hiremath, S. P.; Hiremath, D. M.; Purohit, M. G. Synthesis of substituted 2-(5′-oxo-thioxo-1′,3′,4′-oxadiazol- 2′-yl)-indoles and 2-(5′-oxo-thioxo-1,3,4′-oxadiazol-2′-ylamino)indoles. Indian J. Chem., Sect. B 1983, 22, 571-576.
36. Al-Dossary, F. S.; Ong, L. T.; Correa, A. G.; Starke, J. R. Treatment of childhood tuberculosis with a six month directly observed regimen of only two weeks of daily therapy. Pediatr. Infect. Dis. J. 2002, 21, 91-97.
37. Reuter, K.; Ficner, R. Sequence analysis and overexpression of the Zymomonas mobilis tgt gene encoding tRNA-guanine transglycosylase: purification and biochemical characterization of the enzyme. J. Bacteriol. 1995, 177, 5284-5288.
38. SYBYL, Chemical Information Software, version 6.7; Tripos, Inc.: St. Louis, MO.
39. Gerber, P. R.; Muller, K. MAB, a generally applicable molecular force field for structure modelling in medicinal chemistry. J. Comput.-Aided Mol. Des. 1995, 9, 251-268.
40. Romier, C.; Ficner, R.; Reuter, K.; Suck, D. Purification, crystallization, and preliminary X-ray diffraction studies of tRNA-guanine transglycosylase from Zymomonas mobilis. Proteins 1996, 24, 516-519.
41. Otwinowski, Z. DENZO; Yale University: New Haven, CT.
42. Brunger, A. T.; Adams, P. D.; Clore, G. M.; DeLano, W. L.; Gros, P.; et al. Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr., Sect. D: Biol. Crystallogr. 1998, 54, 905-921.
43. Jones, T. A.; Zou, J. Y.; Cowan, S. W.; Kjeldgaard. Improved methods for binding protein models in electron density maps and the location of errors in these models. Acta Crystallogr A 1991, 47, 110-119.
44. Web site: http://www.mdli.com.
45. Web site: http://www.ibscreen.com.
46. Web site: http://www.chemstar.ru.
47. Web site: http://asinex.com.
48. Web site: http://leadquest.tripos.com.
49. Web site: http://www.ambinter.com.
50. Sadowski, J.; Schwab, C. H.; Gasteiger, J. CORINA, 3D Structrure Generator, version 2.0; University Erlangen-Nürnberg: Erlangen, Germany.
51. Gohlke, H.; Hendlich, M.; Klebe, G. Knowledge-based scoring function to predict protein-ligand interactions. J. Mol. Biol. 2000, 295, 337-356.
52. Rarey, M.; Kramer, B.; Lengauer, T. The particle concept: placing discrete water molecules during protein-ligand docking predictions. Proteins 1999, 34, 17-28.
53. Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.; Cheeseman, J. R.; Zakrzewski, V. G.; Montgomery, J. A., Jr.; Stratmann, R. E.; Burant, J. C.; Dapprich, S.; Millam, J. M.; Daniels, A. D.; Kudin, K. N.; Strain, M. C.; Farkas, O.; Tomasi, J.; Barone, V.; Cossi, M.; Cammi, R.; Mennucci, B.; Pomelli, C.; Adamo, C.; Clifford, S.; Ochterski, J.; Petersson, G. A.; Ayala, P. Y.; Cui, Q.; Morokuma, K.; Malick, D. K.; Rabuck, A. D.; Raghavachari, K.; Foresman, J. B.; Cioslowski, J.; Ortiz, J. V.; Stefanov, B. B.; Liu, G.; Liashenko, A.; Piskorz, P.; Komaromi, I.; Gomperts, R.; Martin, R. L.; Fox, D. J.; Keith, T.; AI-Laham, M. A.; Peng, C. Y.; Nanayakkara, A.; Gonzalez, C.; Challacombe, M.; Gill, P. M. W.; Johnson, B. G.; Chen, W.; Wong, M. W.; Andres, J. L.; Head-Gordon, M.; Replogle, E. S.; Pople, J. A. Gaussian 98; Gaussian, Inc.: Pittsburgh, PA, 1998.
54. Bruenger, A. T. The free R value: a novel statistical quantity for assessing the accuracy of crystal structures. Nature 1992, 355, 472-474.